Extracellular Vesicles as Biomarkers for Vascular Disease
Biomolecules · 20.04.2026 · 16 (4) · 608
DOI: 10.3390/biom16040608 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.04.2026. Verfasst von Davide Costa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology, Univers…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Vascular Diseases. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vascular diseases (VD) remain a leading global cause of morbidity and mortality, often developing silently before manifesting as severe complications like stroke or ischemia. Traditional diagnostic imaging provides essential anatomical data but frequently fails to capture the dynamic molecular processes underlying vascular pathology. This narrative review summarizes current evidence regarding Extracellular Vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, as emerging biomarkers and mediators in vascular conditions. The review evaluates the biological mechanisms of EVs across several disorders, including arterial aneurysms, peripheral artery disease, carotid stenosis, and venous thromboembolism. Findings indicate that EVs concentration and molecular cargo, particularly microRNAs and proteins, reflect the physiological state of parent cells, offering a “liquid biopsy” for vascular inflammation, endothelial dysfunction, and plaque vulnerability. Furthermore, the review explores the therapeutic potential of stem cell-derived EVs in promoting angiogenesis and tissue repair in chronic vascular ulcers. Despite these advances, the review concludes that the clinical implementation of EV-based diagnostics faces significant hurdles, primarily due to the lack of standardized isolation and characterization methods. Addressing these methodological challenges is crucial for translating EV research into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
- Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
- Department of Public Health, University Federico II of Naples, 80138 Naples, Italy.
ORCID-Profile: Davide Costa, Michele Andreucci, Nicola Ielapi, Antonio Mazza, Giulio Accarino, Umberto Marcello Bracale, Raffaele Serra
Zitieren
APA
Costa, D., Andreucci, M., Ielapi, N., Faga, T., Mazza, A., Accarino, G., Bracale, U. M., & Serra, R. (2026). Extracellular Vesicles as Biomarkers for Vascular Disease. Biomolecules, 16(4), 608. https://doi.org/10.3390/biom16040608
Vancouver
Costa D, Andreucci M, Ielapi N, Faga T, Mazza A, Accarino G, et al. Extracellular Vesicles as Biomarkers for Vascular Disease. Biomolecules. 2026;16(4):608. doi:10.3390/biom16040608
BibTeX
@article{Costa2026,
author = {Costa, Davide and Andreucci, Michele and Ielapi, Nicola and Faga, Teresa and Mazza, Antonio and Accarino, Giulio and Bracale, Umberto Marcello and Serra, Raffaele},
title = {Extracellular Vesicles as Biomarkers for Vascular Disease},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {4},
pages = {608},
doi = {10.3390/biom16040608}
}
EUVIMED